Inovio Pharmaceuticals Inc股票

View detailed financial information, real-time news, videos, quotes and analysis on Inovio Pharmaceuticals Inc. (NASDAQ:INO). Explore commentary on Inovio Pharmaceuticals Inc. and hear what the Australian finance news, stock quotes, currency information and blogs Get real-time Inovio Pharmaceuticals (INO) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing. Get the tools used by (smart) 2 investors. 公司简介 Inovio Pharmaceuticals，Inc。是一家后期生物技术公司，专注于基于DNA的免疫疗法和疫苗的发现，开发和商业化，以预防和治疗癌症和传染病。其SynCon免疫疗法设计具有破坏免疫系统对癌细胞的耐受性的能力，并且旨在促进针对已知的以及新的无法匹配的病原体（例如流感）的交叉菌株保护。 Inovio Pharmaceuticals Inc (NASDAQ:INO) has been in the news over the past weeks since it was one of the first companies to have developed and started clinical trials on a coronavirus vaccine. While that is a major plus, it should be noted that there are other factors to consider for those who are looking to invest in the stock.

Inovio Pharmaceuticals Incとは. アイノビオ・ファーマスーティカル(Inovio Pharmaceuticals, Inc.)は癌と感染症の治療・予防に重点を置くデオキシリボ核酸（DNA

Inovio Pharmaceuticals has been making a lot of headlines lately. Thanks to its efforts to develop a vaccine for COVID-19, the company's stock is up by 150% year to date. However, turning ordinary Inovio is well-positioned to become a major pharmaceutical company during the next decade. Approval of VGX-3100 is likely (though not guaranteed). If approved by the FDA, it could start providing significant revenue in 2022, and label expansions could follow quickly. INO-3107 and MEDI0457 could also get approvals and generate revenue in three to four years. 名称: Inovio Pharmaceuticals Inc 行业: Biotechnology 地址: 660 West Germantown Pike 电话: +1 267 440-4200 传真: +1 267 440-4242 网站: https://www.inovio.com 简介: Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的免疫疗法和疫苗，用于治疗和预防癌症和传染病。该公司从事基因治疗，其免疫治疗一个方便快捷的方法分析us股票技术分析仪表显示所选时间范围的实时评分。inovio pharmaceuticals inc的摘要基于最流行的技术指标 - 移动平均线，振荡器和枢轴。结果快速可得

Inovio Pharmaceuticals Inc (NASDAQ:INO) has been in the news over the past weeks since it was one of the first companies to have developed and started clinical trials on a coronavirus vaccine. While that is a major plus, it should be noted that there are other factors to consider for those who are looking to invest in the stock.

Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Inovio Pharmaceuticals（INO）股吧，股票论坛讨论区，让您和专业Inovio Pharmaceuticals Inc股票投资者一起畅所欲言，分析交流Inovio Pharmaceuticals Inc股票的最新动态，行情走势和交易策略。一起讨论Inovio Pharmaceuticals（INO）股票吧。

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat, cure, and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance 美股上市股票Inovio Pharmaceuticals Inc,在NYSE交易所挂牌上市，中文名称Inovio Pharmaceuticals Inc,股票代码。客服热线：010-84185831 扫码关注微信 Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Inovio Pharmaceuticals, Inc. (INO). Watch more INO Technical Analysis Videos: https Inovio Pharmaceuticals Inc said on Thursday it plans to begin human trials of its potential COVID-19 vaccine in South Korea later in June, with support from Seoul-headquartered partner INO Inovio Pharmaceuticals, Inc. Common Stock. Data is currently not available. Latest News. Inovio to Start a Phase 1/2 Study of its COVID-19 Vaccine in South Korea Jun 4, 2020. Inovio Pharmaceuticals, Inc. researches and develops pharmaceuticals. The Company develops cancer DNA and infectious DNA vaccines, anti-inflammatory drugs, and animal health products.

公司简介 Inovio Pharmaceuticals，Inc。是一家后期生物技术公司，专注于基于DNA的免疫疗法和疫苗的发现，开发和商业化，以预防和治疗癌症和传染病。其SynCon免疫疗法设计具有破坏免疫系统对癌细胞的耐受性的能力，并且旨在促进针对已知的以及新的无法匹配的病原体（例如流感）的交叉菌株保护。

获取最新信息并更多了解Inovio Pharmaceuticals, Inc.(INO) 股票杠杆交易. 股票最大可采用5:1 杠杆率进行交易，即投入100 美元可开立500 美元头寸新浪财经-美股频道为您提供INO(INO)股票股价,股票实时行情,新闻,财报,美股实时交易数据,研究报告,评级,财务指标分析等与INO(INO)股票相关的信息与服务. Inovio Pharmaceuticals Inc. INO:NASDAQ. Real Time Quote | Last NYSE Arca, VOL From CTA | USD. Extended Hours. Last Yield | 7:59:24 PM EDT. 12.74 %. 27 Apr 2020 Take, for example Inovio Pharmaceuticals, Inc. (NASDAQ:INO). Its share price is already up an impressive 282% in the last twelve months. Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based 6 Mar 2020 The Plymouth Meeting company earlier this week said it was accelerating its timeline for testing its coronavirus vaccine candidate.